Investors have shunned bargain-priced stocks in favor of fast growers for years. Is value due for a comeback?
Legends of investing, including Benjamin Graham and his disciple Warren Buffett, have long touted the advantages of value investing. Value stocks trade inexpensively compared with corporate measures such as sales, earnings and book value (assets minus liabilities). Historically, they have outperformed growth stocks, which boost earnings and sales faster than their peers. The thinking behind the value strategy is simple: Investors tend to bid up exciting, fast-growing companies to bloated levels and shun boring companies or those going through temporary problems.
When the market eventually comes to its senses and stock prices normalize, value wins. From July 1926 through May 2018, value stocks traded on U.S. stock markets outpaced growth stocks by an annualized 3.9 percentage points.
But for more than a decade, growth stocks have pummeled their bargain priced counterparts. Since the beginning of the last bear market in 2007, Standard & Poor’s 500 Value index, which tracks value oriented components of the broad market barometer, has returned a cumulative 77%, compared with a 179% return in the corresponding growth-stock yardstick. The walloping hasn’t been consistent; value outpaced growth in 2012 and 2016. Led by a still-booming tech sector, growth stocks in the S&P 500 have returned 11.6% so far in 2018, compared with 0.2% for value stocks. (Prices and other data are through July 13.)
Growth stocks usually sparkle in bull markets, but value shares tend to shine in down markets. At least that was the case between 1970 and 2006. When the stock market dropped 55% in the financial crisis and associated bear market of 2007– 09, value should have shone. Except that value-oriented financial firms were at the heart of the mess, and lost 82% over the period. From June 2014 to January 2016, energy stocks, also value stalwarts, lost 42% as oil prices plummeted.
Diese Geschichte stammt aus der September 2018-Ausgabe von Kiplinger's Personal Finance.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der September 2018-Ausgabe von Kiplinger's Personal Finance.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
HOW INFLATION ADJUSTMENTS WILL AFFECT YOUR TAXES
We looked at IRS rules for 2025 on everything from tax brackets to how much you can save in retirement accounts.
GUARD AGAINST IDENTITY THEFT IN THE NEW YEAR
Scammers are getting better at impersonating legitimate businesses.
SHOULD YOU BUY PET HEALTH INSURANCE?
You can fend off big veterinary bills with a policy that covers your furry companion.
THE LOWDOWN ON BUYING A VACATION HOME
If you return to a beloved destination again and again, purchasing a home there may be a smart move-but don't overlook the costs and effort that go into it.
HOW COUPLES CAN MANAGE DIFFERING RETIREMENT TIME LINES
Staggered retirement is increasingly common, but it can create financial and emotional challenges.
AVOID THESE CREDIT MISSTEPS
KIPLINGER ADVISOR COLLECTIVE
WHAT YOU NEED TO KNOW ABOUT WORKING FOR YOURSELF
Whether you're looking for a side gig or planning to start your own business, it has never been easier to strike out on your own.
My Top 10 Stock Picks for 2025
SINCE 1993, I have offered an annual list of 10 stocks with the potential to beat the market in the 12 months ahead. My 2024 selections notched the highest return ever: an average of 48.9%. I beat the S&P 500 index by 10.8 percentage points, and every one of my stocks was up-six by more than 30%.
WHAT MAKES AN ETF SUCCESSFUL?
EXCHANGE-traded funds have exploded in popularity, with the industry now reaching the milestone of $10 trillion in assets.
TIPS FROM INSIDERS
When corporate insiders buy or sell, it can offer clues on whether you should do the same.